MedPath

SANOFI PASTEUR INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

27

Active:21
Completed:0

Trial Phases

3 Phases

Phase 1:14
Phase 3:3
Not Applicable:2

Drug Approvals

5

FDA:5

Drug Approvals

MenQuadfi

Approval Date
May 23, 2025
FDA

FLUZONE HIGH DOSE NORTHERN HEMISPHERE

Approval Date
May 6, 2025
FDA

FLUZONE QIV SH 2025

Approval Date
Mar 21, 2025
FDA

BEYFORTUS

Approval Date
Feb 23, 2024
FDA

TUBERSOL

Approval Date
Jan 25, 2024
FDA

Clinical Trials

Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials

Phase 1
14 (73.7%)
Phase 3
3 (15.8%)
Not Applicable
2 (10.5%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath